Coronavirus Top News
Press Release | January 15, 2021
WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker released the following statement about AdvaMed’s participation on the HHS Vaccine Consultation Panel.
“Big Milestone”: MedTech Industry Has Shipped More Than 255 Million Molecular COVID-19 Tests Nationwide
Press Release | December 7, 2020
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry shows that total U.S. shipments of COVID-19 molecular diagnostic tests have topped more than 255 million since the beginning of the pandemic.
AdvaMed Welcomes Vision 2025 Roadmap to Reinforce Business Integrity Across APEC Region Amidst COVID-19
Press Release | October 27, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) this week joined medtech industry, government and other health care stakeholders at the Asia-Pacific Economic Cooperation (APEC) Business Ethics for Small- and Medium-Sized Enterprises (SMEs) Virtual Forum in welcoming introduction of the Vision 2025 roadmap for reinforcing business integrity across the APEC region amidst COVID-19.
AdvaMed Letter to President Biden on Defense Production Act: Ready to Continue Industry Efforts to Defeat COVID-19
Press Release | January 22, 2021
WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker sent a letter to President Biden affirming the industry’s support of the administration’s national COVID-19 strategy and sharing the industry’s perspective on invocation and use of the Defense Production Act (DPA).
Blog Post | January 22, 2021
Last week, we celebrated an important CMS policy update: Under a new rule, called Medicare Coverage of Innovative Technology (MCIT), as soon as the FDA approves a new breakthrough technology, Medicare can cover that breakthrough technology. Today, in an op-ed in Morning Consult, AdvaMed President and CEO Scott Whitaker encouraged the Biden administration to work with our industry to implement and strengthen the rule, saying, “Too many seniors’ lives depend on it.”
Press Release | January 20, 2021
WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker released the following statement: